Contract LawFeaturedHealth CarePharmaceuticals
House Blocks Chinese Biotech: Great Wall Built, but Who Guarded the Supply Chain?
October 21, 2024By Chelsea Barcenas
On September 9, 2024, the U.S. House of Representatives voted 306-81 in favor of H.R. 8333, known as the Biosecure Act.[i] The Biosecure Act prohibits U.S. companies from entering into contracts with biotechnology “companies of concern” and their U.S. subsidiaries.[ii] Specifically, the bill blocks partnerships with BGI Group, MGI, WuXi AppTec, WuXi Biologics, and […]
